| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,169 |
2,902 |
$267K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
791 |
748 |
$92K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
317 |
313 |
$30K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,566 |
1,218 |
$28K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,894 |
1,808 |
$21K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
629 |
589 |
$19K |
| 87428 |
|
32 |
30 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
62 |
56 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
42 |
40 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25 |
25 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
25 |
25 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$667.03 |
| 87807 |
|
38 |
38 |
$422.56 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
42 |
39 |
$88.36 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
25 |
25 |
$28.00 |